Truvada ne kwaya guda daya, maganin hadewa da aka hada da kwayoyi guda biyu, tenofovir da emtricitabine, dukansu wadanda aka haɗe su ne kamar yadda ƙananan magungunan transcriptase baya transcriptase suke. Ana yin tallace-tallace guda biyu a cikin kasuwa kamar Viread (tenofovir) da Emtriva (emtricitabine, FTC).
Cibiyar Abinci da Harkokin Kiwon Lafiyar Amurka (FDA) ta amince da Truvada a watan Agustan 2004 domin amfani da shi wajen maganin cutar HIV , musamman ga tsofaffi da yara a cikin shekaru 12 da suka auna nauyin kilo 77 (35kg) ko fiye.
An ba da lambar yabo ta FDA a watan Yulin 2012 domin amfani da shi wajen hana rigakafin kamuwa da kwayar cutar HIV a cikin mutane masu haɗari a wani tsarin da ake kira prephylaxis prophylaxis (PrEP) .
Halitta
Kwamfutar da aka kirkiro ta hada da 300mg tenofovir diisopropyl fumarate da 200mg emtricitabine. Bikin mai launin shudi, oblong kwamfutar hannu ne mai rufi na fim kuma an saka shi a gefe guda tare da lamba "701" kuma ɗayan tare da sunan mai amfani "GILEAD."
Yankewa
- Ga marasa lafiya da kwayar cutar HIV: guda ɗaya a cikin kwamfutar hannu, ana daukar su da baki ko kuma ba tare da abinci ba.
- Don yin amfani da shi kamar yadda aka fara: ɗaya daga kwamfutar hannu yau da kullum, an yi ta ba tare da ba tare da abinci ba.
- Ga marasa lafiya da nakasa (koda): an dauki kwamfutar hannu kowace rana 48 idan haɓakar halitta ta kasance tsakanin 30-49mL / minti. Idan a ƙasa da 30mL / minti ko a hemodialysis, kada ku yi amfani .
Umurnai
Ga marasa lafiya da kwayar cutar HIV, dole ne a dauki Truvada a hade tare da wasu magungunan antiretroviral.
Lokacin da aka yi amfani da shi kamar yadda aka fara amfani da shi, an dauki Truvada a kansa a matsayin ɓangare na tsarin rigakafin HIV, wanda ya hada da kwaroron roba da sauran ayyukan jima'i na aminci.
Hanyoyin Kasuwanci
Abubuwa masu rinjaye na yau da kullum da suka haɗa da amfani da Truvada (faruwa a cikin 5% ko žananan lokuta) sun hada da:
- Jiɗa
- Diarrhea
- Wulo
- Sinusitis
- Ciwon kai
- Dizziness
- Dama
- Rash
Contraindications
A matsayinka na doka, duk wani nau'in hade da aka hada da tenofovir, emtricitabine ko lamivudine (wani magani na NRTI da ke kama da emtricitabine) bai kamata a dauki shi tare da Truvada ba.
- Kwayoyin maganin kwayar cutar ta HIV: Atripla (tenofovir + emtricitabine + efavirenz), Combivir (Retrovir + lamivudine), kammala (tenofovir + emtricitabine + rilpivirine), Emtriva (emtricitabine, FTC), Epivir (lamivudine, 3TC), Epzicom (abacavir + lamivudine) , Stribild (tenofovir + emtricitabine + elvitegravir + cobicistat), Triumeq (abacavir + lamivudine + dolutegravir), Trizivir (Retrovir + abacavir + lamivudine), Viread (tenofovir)
- Hepatitis B magani: Hepsera (adefovir)
Harkokin hulɗa
Yi shawara ga likitanka idan kana shan wani daga cikin wadannan:
- Anticoagulants: Lixiana (edoxaban), Pradaxa (dabigatran)
- Magungunan ciwon daji na kananan kwayoyin halitta: Ofev / Vargatef (nintedanib)
Ra'ayin Nazarin
Dole ne a yi amfani da Truvada tare da kulawa da marasa lafiya tare da tarihin ƙuntataccen koda (koda). Yi la'akari akai-akai game da ƙwayar halittar mahaifa kafin farawa magani. A cikin marasa lafiya tare da hadarin ƙwayar cutar rash, sun haɗa da ƙaddarar kirkirar mahaifa, magani na phosphorus, furotin glucose da furotin furotin lokacin saka idanu.
Kulawa ya kamata a dauka lokacin da yake hulɗa tare da Truvada tare da kwayar cutar ta HIV ta Videx (didanosine). Duk da yake ba a fahimci hanyoyin da ake hulɗa ba, binciken ya nuna cewa gwamnatin hadin gwiwa na iya kara yawan zubar da jini na Videx kuma ƙara yawan yiwuwar abubuwa masu ban tsoro (misali, pancreatic, neuropathy).
Ana bada shawarar cewa an rage Videx zuwa 250mg cikin marasa lafiya wanda yayi kimanin kilo 132 (60kg) ko fiye.
Bayanan mutum da dabba da ke samuwa suna nuna cewa Truvada baya ƙara haɗarin cutar haihuwa a lokacin daukar ciki . Duk da haka, saboda sakamakon 10ofovir da emtricitabine a kan jarirai ba a sani ba, ana gargadi iyaye kada suyi nono idan sun kama Truvada.
Sources:
Cibiyar Abinci da Druggun Amurka (FDA). "FDA ta amince da maganin maganin cutar ta HIV-1 da ke tattare da kwayar cutar." Silver Spring, Maryland; sanarwa da aka bayar ranar 2 ga Agusta, 2004.
FDA. "FDA ta amince da miyagun ƙwayoyi na farko don rage hadarin samun kamuwa da HIV." Silver Spring, Maryland; sanarwa da aka bayar ranar 16 ga Yuli, 2012.